ACETAMINOPHEN
- Product NDC
- 70010-161
- 11-digit product format
- 700100161
- Labeler code
- 70010
- Product ID
- 70010-161_5d4ed747-ce30-9f26-e063-6394a90a5956
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- ACETAMINOPHEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Granules Pharmaceuticals Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2022-02-15
- Substance
- ACETAMINOPHEN
- Active strength
- 500 mg/1
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-04-01 07:37 UTC · source 2025-03-31 | unfinished product | product | e30019b0c005… | a3f0b14938b7… | |
| 2025-04-01 07:37 UTC · source 2025-03-31 | unfinished package | package | 70010-161-10 | e30019b0c005… | a3f0b14938b7… |
| 2025-04-01 07:37 UTC · source 2025-03-31 | unfinished package | package | 70010-161-05 | e30019b0c005… | a3f0b14938b7… |
| 2025-04-01 07:37 UTC · source 2025-03-31 | unfinished package | package | 70010-161-01 | e30019b0c005… | a3f0b14938b7… |
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished product | product | bbbc9f937eca… | 946b9c97cf81… | |
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished package | package | 70010-161-10 | bbbc9f937eca… | 946b9c97cf81… |
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished package | package | 70010-161-05 | bbbc9f937eca… | 946b9c97cf81… |
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished package | package | 70010-161-01 | bbbc9f937eca… | 946b9c97cf81… |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished product | product | f268b84574a6… | 26285f5ac5df… | |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished package | package | 70010-161-10 | f268b84574a6… | 26285f5ac5df… |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished package | package | 70010-161-05 | f268b84574a6… | 26285f5ac5df… |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished package | package | 70010-161-01 | f268b84574a6… | 26285f5ac5df… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ACETAMINOPHEN
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ACETAMINOPHEN | 500 mg/1 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70010-161-01 | ACETAMINOPHEN | 1 in 1 CARTON | TABLET | 1 | 5 | |
| 70010-161-01 | ACETAMINOPHEN | 100 in 1 BOTTLE | TABLET | 100 | 5 | |
| 70010-161-05 | ACETAMINOPHEN | 500 in 1 BOTTLE | TABLET | 500 | 5 | |
| 70010-161-10 | ACETAMINOPHEN | 1000 in 1 BOTTLE | TABLET | 1000 | 5 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70010-161-01 | EA - Each | 70010-161 | 0ed1eb5c-3333-4e86-b023-551784d2efd3 | 1 | 2023-08-08 |
| 70010-161-05 | EA - Each | 70010-161 | 2e1e4e0f-4cc6-437a-aa64-bf9985bbf911 | 1 | 2023-08-08 |
| 70010-161-10 | EA - Each | 70010-161 | 70fddc44-fb63-4964-a389-6514804206a8 | 1 | 2024-02-14 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Low Dose Aspiriun | ASPIRIN | AMERIFOODS TRADING COMPANY | 3802c96a-5e2a-ba9c-e063-6394a90abb78 | 2025-11-20 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | HYVEE INC | 4227aeb1-dd2c-9ca1-e063-6294a90ad709 | 2025-11-20 | Warnings | M013 |
| good sense pain relief | ACETAMINOPHEN | NuCare Pharamceuticals, Inc. | 440c13d7-edf0-f611-e063-6394a90af995 | 2025-11-20 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | HYVEE INC | 4227a2cc-69fa-869d-e063-6294a90a1d41 | 2025-11-20 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | HYVEE INC | 422796ed-7558-f7e8-e063-6294a90ad1c7 | 2025-11-20 | Warnings | M013 |
| Pain Relief | ACETAMINOPHEN | HYVEE INC | 3e61abe4-b4be-01af-e063-6394a90a8b24 | 2025-11-20 | Warnings | M013 |
| Pain Relief PM | ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE | HYVEE INC | 3e60703b-a5cf-333a-e063-6394a90a2087 | 2025-11-20 | Warnings | M013 |
| ASPIRIN | ASPIRIN | CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED | 54e4ae54-caf8-4105-8428-256f56a2f68f | 2025-11-19 | Warnings | M013 |
| MIDOL COMPLETE | ACETAMINOPHEN, CAFFEINE, AND PYRILAMINE MALEATE | R J General Corporation | 0c09a178-1a07-4079-b4a6-d1657cb8e714 | 2025-11-17 | Warnings | M013 |
| Alka-Seltzer Original | ANHYDROUS CITRIC ACID, ASPIRIN, AND SODIUM BICARBONATE | R J General Corporation | dbb0d067-71f0-45e4-bc98-548cf4a90b3a | 2025-11-17 | Warnings | M013 |
| MOTRIN IB | IBUPROFEN | R J General Corporation | afa87bb5-7fcb-4ccd-acac-f7931242181f | 2025-11-17 | Warnings | M013 |
| TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | R J General Corporation | 99e45e83-37a3-44df-9a2a-98ba7457a5bb | 2025-11-17 | Warnings | M013 |
| TYLENOL PM EXTRA STRENGTH | ACETAMINOPHEN | R J General Corporation | a40ea0e3-d666-4605-b5e0-beeaf8f586f2 | 2025-11-17 | Warnings | M013 |
| Acetaminophen 250 mg and Ibuprofen 125 mg | ACETAMINOPHEN 250 MG AND IBUPROFEN 125 MG | R J General Corporation | 68d3be55-9340-4cc9-a05a-12b9338ddc56 | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | dd9aaf80-6c2b-41a3-87b9-61642aaed4f0 | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c18a2da-1718-4c00-aea8-9fb4a3418312 | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | cd3060a5-3b90-42e4-89cd-3b620859045f | 2025-11-17 | Warnings | M013 |
| Ibuprofen 200 mg | IBUPROFEN | R J General Corporation | 1c7221ae-52d1-4d18-b586-c47ff656150d | 2025-11-17 | Warnings | M013 |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | R J General Corporation | 907c89e7-2482-465f-9f85-2381ecab1b86 | 2025-11-17 | Warnings | M013 |
| Bayer Genuine Aspirin | ASPIRIN | R J General Corporation | 23daa359-d40f-4f64-81be-6d154f41df9f | 2025-11-17 | Warnings | M013 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | d5d49146-665e-4a93-e053-2995a90aca59 | 5 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | d5d49146-665e-4a93-e053-2995a90aca59 | 5 |
| 198440 | APAP 500 MG Oral Tablet | SY | d5d49146-665e-4a93-e053-2995a90aca59 | 5 |
| 198440 | acetaminophen 500 MG Oral Tablet | PSN | 4965fc33-f815-d49e-e063-6394a90a119c | 1 |
| 198440 | acetaminophen 500 MG Oral Tablet | SCD | 4965fc33-f815-d49e-e063-6394a90a119c | 1 |
| 198440 | APAP 500 MG Oral Tablet | SY | 4965fc33-f815-d49e-e063-6394a90a119c | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70010-161-01 | 70010016101 | 1 BOTTLE in 1 CARTON (70010-161-01) / 100 TABLET in 1 BOTTLE | 1 bottle | 2022-02-15 | 0000-00-00 | No | No | Current |
| 70010-161-05 | 70010016105 | 500 TABLET in 1 BOTTLE (70010-161-05) | 500 tablet | 2022-02-15 | 0000-00-00 | No | No | Current |
| 70010-161-10 | 70010016110 | 1000 TABLET in 1 BOTTLE (70010-161-10) | 1000 tablet | 2022-02-15 | No | No | Current |